NASDAQ:ALLO   Allogene Therapeutics, Inc.
I expect medium-term growth in the framework of wave III. up to level 41$

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.